Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.

Buiten RA, Ploumen EH, Zocca P, Doggen CJM, Danse PW, Schotborgh CE, Scholte M, van Houwelingen KG, Stoel MG, Hartmann M, Tjon Joe Gin RM, Somi S, Linssen GCM, Kok MM, von Birgelen C.

JACC Cardiovasc Interv. 2019 Sep 9;12(17):1650-1660. doi: 10.1016/j.jcin.2019.04.054. Epub 2019 Aug 14.

PMID:
31422087
2.

Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial.

Buiten RA, Ploumen EH, Zocca P, Doggen CJM, van der Heijden LC, Kok MM, Danse PW, Schotborgh CE, Scholte M, de Man FHAF, Linssen GCM, von Birgelen C.

JAMA Cardiol. 2019 Jul 1;4(7):659-669. doi: 10.1001/jamacardio.2019.1776.

PMID:
31111862
3.

In search of the most cost-effective monitoring strategy for vestibular schwannoma: A decision analytical modelling study.

Scholte M, Hentschel MA, Hannink G, Kunst HPM, Steens SC, Rovers MM, Grutters JPC.

Clin Otolaryngol. 2019 Jul;44(4):525-533. doi: 10.1111/coa.13326. Epub 2019 Apr 11.

PMID:
30864276
4.
5.

Appropriate use criteria for optical coherence tomography guidance in percutaneous coronary interventions : Recommendations of the working group of interventional cardiology of the Netherlands Society of Cardiology.

IJsselmuiden AJJ, Zwaan EM, Oemrawsingh RM, Bom MJ, Dankers FJWM, de Boer MJ, Camaro C, van Geuns RJM, Daemen J, van der Heijden DJ, Jukema JW, Kraaijeveld AO, Meuwissen M, Schölzel BE, Pundziute G, van der Harst P, van Ramshorst J, Dirksen MT, Zivelonghi C, Agostoni P, van der Heyden JAS, Wykrzykowska JJ, Scholte MJ, Nef HM, Kofflard MJM, van Royen N, Alings M, Kedhi E.

Neth Heart J. 2018 Oct;26(10):473-483. doi: 10.1007/s12471-018-1143-z. Review.

6.

High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial.

Zocca P, Kok MM, van der Heijden LC, Danse PW, Schotborgh CE, Scholte M, Hartmann M, Linssen GCM, Doggen CJM, von Birgelen C.

Cardiovasc Drugs Ther. 2018 Dec;32(6):567-576. doi: 10.1007/s10557-018-6823-9.

7.

Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial.

Kok MM, Zocca P, Buiten RA, Danse PW, Schotborgh CE, Scholte M, Hartmann M, Stoel MG, van Houwelingen G, Linssen GCM, Doggen CJM, von Birgelen C.

EuroIntervention. 2018 Oct 20;14(8):915-923. doi: 10.4244/EIJ-D-18-00336.

8.

Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population.

Kok MM, von Birgelen C, Sattar N, Zocca P, Löwik MM, Danse PW, Schotborgh CE, Scholte M, Hartmann M, Kant GD, Doelman C, Tjon Joe Gin M, Stoel MG, van Houwelingen G, Linssen GCM, IJzerman MJ, Doggen CJM, van der Heijden LC.

EuroIntervention. 2018 Oct 12;14(9):e1049-e1056. doi: 10.4244/EIJ-D-17-01067.

9.

Potential savings in the diagnosis of vestibular schwannoma.

Scholte M, Hentschel MA, Kunst HP, Steens SCA, Rovers MM, Grutters JPC.

Clin Otolaryngol. 2018 Feb;43(1):285-290. doi: 10.1111/coa.12973. Epub 2017 Sep 7.

PMID:
28834261
10.

Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.

Chatzidionysiou K, Emamikia S, Nam J, Ramiro S, Smolen J, van der Heijde D, Dougados M, Bijlsma J, Burmester G, Scholte M, van Vollenhoven R, Landewé R.

Ann Rheum Dis. 2017 Jun;76(6):1102-1107. doi: 10.1136/annrheumdis-2016-210711. Epub 2017 Mar 29. Review.

PMID:
28356243
11.

The diagnostic accuracy of non-imaging screening protocols for vestibular schwannoma in patients with asymmetrical hearing loss and/or unilateral audiovestibular dysfunction: a diagnostic review and meta-analysis.

Hentschel M, Scholte M, Steens S, Kunst H, Rovers M.

Clin Otolaryngol. 2017 Aug;42(4):815-823. doi: 10.1111/coa.12788. Epub 2016 Dec 1. Review.

PMID:
27905190
12.

Data extraction from electronic health records (EHRs) for quality measurement of the physical therapy process: comparison between EHR data and survey data.

Scholte M, van Dulmen SA, Neeleman-Van der Steen CW, van der Wees PJ, Nijhuis-van der Sanden MW, Braspenning J.

BMC Med Inform Decis Mak. 2016 Nov 8;16(1):141.

13.

Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.

von Birgelen C, Kok MM, van der Heijden LC, Danse PW, Schotborgh CE, Scholte M, Gin RMTJ, Somi S, van Houwelingen KG, Stoel MG, de Man FHAF, Louwerenburg JHW, Hartmann M, Zocca P, Linssen GCM, van der Palen J, Doggen CJM, Löwik MM.

Lancet. 2016 Nov 26;388(10060):2607-2617. doi: 10.1016/S0140-6736(16)31920-1. Epub 2016 Oct 30.

PMID:
27806902
14.

The Reasons behind the (Non)Use of Feedback Reports for Quality Improvement in Physical Therapy: A Mixed-Method Study.

Scholte M, Neeleman-van der Steen CW, van der Wees PJ, Nijhuis-van der Sanden MW, Braspenning J.

PLoS One. 2016 Aug 12;11(8):e0161056. doi: 10.1371/journal.pone.0161056. eCollection 2016.

15.

First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting.

Lu H, IJsselmuiden AJ, Grundeken MJ, Nassif M, de Vries AG, Weevers A, Scholte M, Spaargaren R, Wykrzykowska JJ, Tijssen JG, de Winter RJ, Koch KT.

EuroIntervention. 2016 Mar;11(12):1341-5. doi: 10.4244/EIJY15M05_07.

16.

Quality of physical therapy from a patient's perspective; factor analysis on web-based survey data revealed three dimensions on patient experiences with physical therapy.

Scholte M, Calsbeek H, Nijhuis-van der Sanden MW, Braspenning J.

BMC Health Serv Res. 2014 Jun 18;14:266. doi: 10.1186/1472-6963-14-266.

17.

Evaluating quality indicators for physical therapy in primary care.

Scholte M, Neeleman-van der Steen CW, Hendriks EJ, Nijhuis-van der Sanden MW, Braspenning J.

Int J Qual Health Care. 2014 Jun;26(3):261-70. doi: 10.1093/intqhc/mzu031. Epub 2014 Apr 3.

PMID:
24699199
18.

Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): rationale and study design of the randomized TWENTE III multicenter trial.

Lam MK, Sen H, Tandjung K, van Houwelingen KG, de Vries AG, Danse PW, Schotborgh CE, Scholte M, Löwik MM, Linssen GC, Ijzerman MJ, van der Palen J, Doggen CJ, von Birgelen C.

Am Heart J. 2014 Apr;167(4):445-51. doi: 10.1016/j.ahj.2013.11.014. Epub 2014 Jan 6. Review.

19.

GOLLUM [FeFe]-hydrogenase-like proteins are essential for plant development in normoxic conditions and modulate energy metabolism.

Mondy S, Lenglet A, Cosson V, Pelletier S, Pateyron S, Gilard F, Scholte M, Brocard L, Couzigou JM, Tcherkez G, Péan M, Ratet P.

Plant Cell Environ. 2014 Jan;37(1):54-69. doi: 10.1111/pce.12128. Epub 2013 May 29.

20.

Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: the EXAMI study.

Bernink FJ, Timmers L, Diamant M, Scholte M, Beek AM, Kamp O, Marques KM, Denham RN, Chen WJ, Doevendans PA, van Rossum AC, van Royen N, Horrevoets AJ, Appelman Y.

Int J Cardiol. 2013 Jul 15;167(1):289-90. doi: 10.1016/j.ijcard.2012.09.204. Epub 2012 Oct 18. No abstract available.

21.

Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial.

Scholte M, Timmers L, Bernink FJ, Denham RN, Beek AM, Kamp O, Diamant M, Horrevoets AJ, Niessen HW, Chen WJ, van Rossum AC, van Royen N, Doevendans PA, Appelman Y.

Trials. 2011 Nov 8;12:240. doi: 10.1186/1745-6215-12-240.

22.

Endosomal escape pathways for delivery of biologicals.

Varkouhi AK, Scholte M, Storm G, Haisma HJ.

J Control Release. 2011 May 10;151(3):220-8. doi: 10.1016/j.jconrel.2010.11.004. Epub 2010 Nov 13. Review.

PMID:
21078351
23.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, van Vollenhoven R, Winthrop KL, Wong J, Zink A, van der Heijde D.

Ann Rheum Dis. 2010 Jun;69(6):964-75. doi: 10.1136/ard.2009.126532. Epub 2010 May 5. Review. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

24.

An improved purification procedure for the soluble [NiFe]-hydrogenase of Ralstonia eutropha: new insights into its (in)stability and spectroscopic properties.

van der Linden E, Burgdorf T, de Lacey AL, Buhrke T, Scholte M, Fernandez VM, Friedrich B, Albracht SP.

J Biol Inorg Chem. 2006 Mar;11(2):247-60. Epub 2006 Jan 18.

PMID:
16418856
25.

Crystal structures of recombinant human purple Acid phosphatase with and without an inhibitory conformation of the repression loop.

Sträter N, Jasper B, Scholte M, Krebs B, Duff AP, Langley DB, Han R, Averill BA, Freeman HC, Guss JM.

J Mol Biol. 2005 Aug 5;351(1):233-46. Epub 2005 Apr 26.

PMID:
15993892
26.

Transformation of floral organs with GFP in Medicago truncatula.

Kamaté K, Rodriguez-Llorente ID, Scholte M, Durand P, Ratet P, Kondorosi E, Kondorosi A, Trinh TH.

Plant Cell Rep. 2000 Jun;19(7):647-653. doi: 10.1007/s002999900168.

PMID:
30754800
27.

German health system slow to change.

Scholte M, Doherty J.

Manag Care Q. 1998 Spring;6(2):68-70. No abstract available.

PMID:
10181709
28.
29.
30.

Affinity of glucose transport in Saccharomyces cerevisiae is modulated during growth on glucose.

Walsh MC, Smits HP, Scholte M, van Dam K.

J Bacteriol. 1994 Feb;176(4):953-8.

31.

Rapid kinetics of glucose uptake in Saccharomyces cerevisiae.

Walsh MC, Smits HP, Scholte M, Smits G, van Dam K.

Folia Microbiol (Praha). 1994;39(6):557-9.

PMID:
8550023
32.
33.

Changes in the incorporation of carbon derived from glucose into cellular pools during the cell cycle of Saccharomyces cerevisiae.

Oehlen LJ, van Doorn J, Scholte ME, Postma PW, van Dam K.

J Gen Microbiol. 1990 Mar;136(3):413-8.

PMID:
2202778
34.

Changes in activities of several enzymes involved in carbohydrate metabolism during the cell cycle of Saccharomyces cerevisiae.

Van Doorn J, Valkenburg JA, Scholte ME, Oehlen LJ, Van Driel R, Postma PW, Nanninga N, Van Dam K.

J Bacteriol. 1988 Oct;170(10):4808-15.

35.

Regulation of trehalase activity during the cell cycle of Saccharomyces cerevisiae.

Van Doorn J, Scholte ME, Postma PW, Van Driel R, Van Dam K.

J Gen Microbiol. 1988 Mar;134(3):785-90.

PMID:
3053978
36.

Mercury in flounder, Platichtys flesus, cod, Gadus morhua, and perch, Perca fluviatilis, in relation to their length and environment.

Luten JB, Bouquet W, Riekwel-Booy G, Rauchbaar AB, Scholte MW.

Bull Environ Contam Toxicol. 1987 Feb;38(2):318-23. No abstract available.

PMID:
3801704
37.

The production of high potency diphtheria toxin in submerged culture in relatively simple equipment using a semisynthetic medium.

Stainer DW, Scholte MJ.

Biotechnol Bioeng Symp. 1973;0(4-1):283-93. No abstract available.

PMID:
4213472
38.

A simple chemically defined medium for the production of phase I Bordetella pertussis.

Stainer DW, Scholte MJ.

J Gen Microbiol. 1970 Oct;63(2):211-20. No abstract available.

PMID:
4324651
39.

Preparation and properties of diphtheria toxoids in submerged culture. IV. A revised method for the purification of diphtheria toxin.

Robb LA, Stainer DW, Scholte MJ.

Can J Microbiol. 1970 Jul;16(7):639. No abstract available.

PMID:
4990522
40.

Preparation and properties of diphtheria toxoids in submerged culture. 3. Development of a new semisynthetic medium.

Stainer DW, Corkill JM, Scholte MJ.

Can J Microbiol. 1968 Oct;14(10):1155-60. No abstract available.

PMID:
5681528

Supplemental Content

Loading ...
Support Center